Combining mechanical bowel preparation with oral antibiotics significantly reduces complications after elective colectomy for colon cancer. Surgical site infection dropped from 8.7% without prep to 5.0% with combined prep. All bowel prep regimens lowered the risk of postoperative complications versus no prep, with combined prep showing the best relative risk reduction (infection: 0.60, leak: 0.66, […]
Category: Intestine and Lower Gastrointestinal Tract
International Consensus on Presacral Tumor Management
This consensus sets new guidelines for diagnosing and managing presacral tumors, enhancing surgical practices and patient outcomes. High-resolution MRI with structured reporting is crucial for risk stratification. Image-guided biopsies are necessary for high-risk lesions needing histological confirmation. Tailor surgical approaches to tumor biology, with complete resection as the goal. Non-operative surveillance is advocated for low-risk, […]
Omitting Lateral Node Dissection in Rectal Cancer Safe
Lateral pelvic lymph node dissection in rectal cancer patients with responsive nodes after neoadjuvant therapy shows no survival benefit, impacting surgical strategies. No significant differences in 5-year local recurrence rates (3.1% vs. 5.3%), disease-free survival (77.1% vs. 71.4%), or overall survival (87.0% vs. 86.9%) with or without dissection. Dissection led to longer operative times (279.3 […]
Multimodal Prehabilitation Cuts Complications in Colorectal Surgery
A national study shows that multimodal prehabilitation significantly reduces complications in colorectal cancer surgery, improving outcomes for patients. Overall complication rates dropped from 37.8% to 30.1% in the prehabilitation group (odds ratio 0.71). Medical complications decreased from 24.6% to 15.4% (odds ratio 0.56). Length of hospital stay was reduced by 1 day, from 5 to […]
Survival Tied to Timely, Guideline-Concordant Care in Cancer
Optimal treatment timing significantly impacts survival in localized colon, lung, and pancreatic cancers. 68.7% of colon cancer, 70.6% of non-small cell lung cancer (NSCLC), and 22.6% of pancreatic cancer patients received optimal care. Patients receiving optimal care had much lower death risk: colon cancer HR 0.45, NSCLC HR 0.35, pancreatic cancer HR 0.46. Optimal care’s […]
Trends in Perioperative Chemotherapy for Colorectal Liver Metastases
Perioperative chemotherapy shows a survival edge for patients undergoing hepatectomy for colorectal liver metastases, but use is declining. Among 3,752 patients who had surgery, 54% received some form of perioperative chemotherapy. Survival improved significantly with both pre- and postoperative regimens (hazard ratio, 0.54). Complication risks and patient selection remain crucial; higher use is seen in […]
Postdischarge risks in nonoperative diverticulitis care
Nonoperative management of complicated diverticulitis significantly increases readmission risks. 33.9% of nonoperatively managed patients were readmitted due to recurrence, compared to just 4.8% of those who underwent surgery. Nonoperatively managed patients had 9-fold higher odds of readmission and were 3 times more likely to need surgery upon readmission. Surgeons should carefully consider the need for […]
Adjuvant Radiation Therapy Boosts Survival in Early Anal Cancer
Patients with T1-2 N0 anal squamous cell carcinoma benefit significantly from adjuvant radiation therapy after local excision. Five-year overall survival rates were 82.8% with radiation versus 74.9% without (p < .001). The benefit was especially marked in those with positive surgical margins (79.9% vs 67.2%; p = .003) and in women ≥65 years (85.8% vs […]
NAPRC Accreditation Increases Rectal Cancer Patient Volume
Accreditation for rectal cancer is linked to higher patient volumes and early-stage procedures. Naprc-accredited hospitals saw an annual increase of 4.3 rectal cancer patients per institution. Accreditation boosted stage I procedure volume, with a gain of 1.01 procedures (p=0.05). Improving accreditation may support institutional growth without sacrificing care quality. Care fragmentation remained unchanged, indicating continuity […]
Surgeons Should Rethink Approach for Anal SCC Surgery
Local excision offers better survival than abdominoperineal resection for anal squamous cell carcinoma post-chemoradiotherapy. 5-year overall survival: 75% for local excision vs. 46.1% for abdominoperineal resection (p < .001). Local excision had lower 90-day mortality (0.9% vs. 5.1%, p < .001) and lower 30-day readmission rates (1.5% vs. 7.7%, p < .001). Despite more positive […]